Healthcare & biotech innovation ETFs: Riding medtech and gene therapy waves
The healthcare and biotechnology industries have always been at the forefront of human progress — but in 2025, they’re transforming faster than ever before. From breakthroughs in gene editing and regenerative medicine to advances in medical devices, digital health, and artificial intelligence diagnostics, innovation in healthcare isn’t just saving lives — it’s reshaping global markets. For investors, Healthcare & Biotech Innovation ETFs are providing a powerful and diversified way to tap into this revolution. These funds offer exposure to the companies driving medical innovation, patient access, and next-generation therapies that are redefining the future of medicine.
This article explores why this sector is booming, the science and technology powering it, and the major ETFs capturing its momentum.
🔔 Don’t miss out!
Add winvestacrisps@substack.com to your email list so our updates never land in spam
Keep reading with a 7-day free trial
Subscribe to Winvesta Crisps to keep reading this post and get 7 days of free access to the full post archives.